New Scientist reports: The use of QuikClot for treating bleeding wounds results in hemostasis that is five times faster than existing medications.
 |
Quikclot (Photo: CAND) |
Scientists Galen Stucky and Todd Ostomel, along with their colleagues at California State University, have successfully developed a new hemostatic agent called QuikClot. This medication is produced in a mineral-colored, porous powder form and contains silver ions.
According to New Scientist on March 20, using QuikClot for bleeding wounds achieves hemostasis five times faster than current medications. In experiments conducted on pigs, QuikClot ensured the survival of all animals suffering from arterial bleeding, while traditional methods could only save 50% of the cases.
Currently, several military hospitals of the U.S. police and joint forces in Iraq and Afghanistan are using QuikClot to treat bleeding wounds.
According to data from the manufacturer, Z-Medica, this new hemostatic agent has saved the lives of at least 150 U.S. police officers and military personnel. In the near future, QuikClot will be widely used in hospitals and available for purchase at pharmacies across the United States.
Ngọc Linh
